Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 92437
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.92437
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.92437
Figure 3 Prospective molecular mechanisms of transmembrane protein 106C underlying pan-cancers.
A: Gene set enrichment analysis was conducted across 33 cancer types to rank the enriched transmembrane protein 106C (TMEM106C) pathways; B-E: Gene set enrichment analysis results for TMEM106C in adrenocortical carcinoma, bladder cancer, breast cancer, and hepatocellular carcinoma, respectively. ECM: Extracellular matrix.
- Citation: Li JD, He RQ, Dang YW, Huang ZG, Xiong DD, Zhang L, Du XF, Chen G. Unveiling expression patterns, mechanisms, and therapeutic opportunities of transmembrane protein 106C: From pan-cancers to hepatocellular carcinoma. World J Gastrointest Oncol 2025; 17(2): 92437
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/92437.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.92437